A large portion of human cancers is characterized by mutations in genes encoding SWI/SNF subunits; furthermore, some oncogenes like MYC and KRAS can interact with SWI/SNF subunits promoting cancer progression in leukemia, lung and colon cancer cells. This evidence concerns the gene SMARCA1 and malignant colon neoplasm.